for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Video Module

Biotechnology sector rides wave of vaccine rollouts

Posted

The biotechnology sector has directly benefited from the global drive to produce and distribute a coronavirus vaccine. But with vaccines now rolling out, further upside may be limited. Patrick Healey, President of Caliber Financial Partners, explains why he thinks there are other aspects of the sector that investors should be looking at.

Video Module

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up